DexCom Valuation
| DXCM Stock | USD 66.60 0.27 0.41% |
At this time, the firm appears to be undervalued. DexCom Inc shows a prevailing Real Value of $80.45 per share. The current price of the firm is $66.6. Our model computes the value of DexCom Inc from reviewing the firm fundamentals such as Profit Margin of 0.13 %, shares outstanding of 392.16 M, and Current Valuation of 25.7 B as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that DexCom's price fluctuation is very steady at this time. Calculation of the real value of DexCom Inc is based on 3 months time horizon. Increasing DexCom's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the DexCom stock is determined by what a typical buyer is willing to pay for full or partial control of DexCom Inc. Since DexCom is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DexCom Stock. However, DexCom's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 66.6 | Real 80.45 | Hype 67.2 | Naive 67.54 |
The intrinsic value of DexCom's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DexCom's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DexCom Inc helps investors to forecast how DexCom stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DexCom more accurately as focusing exclusively on DexCom's fundamentals will not take into account other important factors: DexCom Total Value Analysis
DexCom Inc is currently forecasted to have valuation of 25.7 B with market capitalization of 26.01 B, debt of 2.59 B, and cash on hands of 2.37 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the DexCom fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
25.7 B | 26.01 B | 2.59 B | 2.37 B |
DexCom Investor Information
About 97.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.85. DexCom Inc had not issued any dividends in recent years. The entity had 4:1 split on the 13th of June 2022. DexCom Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in November.DexCom Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DexCom has an asset utilization ratio of 62.19 percent. This suggests that the Company is making $0.62 for each dollar of assets. An increasing asset utilization means that DexCom Inc is more efficient with each dollar of assets it utilizes for everyday operations.DexCom Ownership Allocation
DexCom holds a total of 392.16 Million outstanding shares. The majority of DexCom Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in DexCom Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in DexCom. Please pay attention to any change in the institutional holdings of DexCom Inc as this could imply that something significant has changed or is about to change at the company. On July 9, 2025, Representative Michael McCaul of US Congress acquired $15k to $50k worth of DexCom Inc's common stock.DexCom Profitability Analysis
The company reported the previous year's revenue of 4.03 B. Net Income was 576.2 M with profit before overhead, payroll, taxes, and interest of 2.53 B.About DexCom Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of DexCom Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of DexCom Inc based exclusively on its fundamental and basic technical indicators. By analyzing DexCom's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of DexCom's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of DexCom. We calculate exposure to DexCom's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DexCom's related companies.DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California. Dexcom operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 6300 people.
DexCom Growth Indicators
Investing in growth stocks can be very risky. If the company such as DexCom does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 412.7 M | |
| Quarterly Earnings Growth Y O Y | 0.274 | |
| Forward Price Earnings | 25.641 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.